Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Brian Keith Gamble , MD

General Practice • Los Angeles, CA

Active NPI 1568478436 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

4300 Crenshaw Blvd
Los Angeles, CA 900084902

Call 3232981668 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

4300 Crenshaw Blvd

Los Angeles, CA 900084902

Telephone 3232981668
Fax 3232980458
Organization at the Same NPPES Address or Phone
Lake Side Medical Center Professional. Inc. Facility NPI 1740572395

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

Meharry Medical College School Of Medicine

Graduation Year

1997

Medicare patients

571 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $663,503 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $508,809 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

13,953 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$933,924 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $538.55 across 24 records.

By nature of payment

  • Food and Beverage: $538.55 across 24 records.

Reporting-company totals (3 largest of 5)

  • ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $279.32 across 14 records.
  • Teva Pharmaceuticals USA, Inc.: $82.42 across 3 records.
  • Xeris Pharmaceuticals, Inc.: $60.05 across 3 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

29 years (graduated 1997)

CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Compared with the same specialty in Los Angeles and California

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 85% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: 897. Middle half: 160 to 4,894.

More Medicare Part B services than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: 485. Middle half: 154 to 2,031.

Medicare-allowed amount

A higher Medicare-allowed amount than 80% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: $84,340. Middle half: $14,329 to $427,622.

A higher Medicare-allowed amount than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: $45,658. Middle half: $14,895 to $165,622.

Paid by Medicare

A higher Medicare payment amount than 80% of clinicians listed under General Practice in Los Angeles, CA (2024, 39 clinicians with data). Median for this group: $59,034. Middle half: $10,306 to $334,098.

A higher Medicare payment amount than 90% of clinicians listed under General Practice in California (2024, 411 clinicians with data). Median for this group: $32,130. Middle half: $11,289 to $132,947.

Medicare Part D prescriptions

More Part D prescriptions than 90% of clinicians listed under General Practice in Los Angeles, CA (2024, 73 clinicians with data). Median for this group: 911. Middle half: 99 to 3,151.

More Part D prescriptions than 90% of clinicians listed under General Practice in California (2024, 609 clinicians with data). Median for this group: 755. Middle half: 125 to 3,708.

Part D drug cost

A higher Part D drug cost than 90% of clinicians listed under General Practice in Los Angeles, CA (2024, 73 clinicians with data). Median for this group: $35,867. Middle half: $1,749 to $228,354.

A higher Part D drug cost than 90% of clinicians listed under General Practice in California (2024, 609 clinicians with data). Median for this group: $49,322. Middle half: $2,066 to $279,323.

169 active clinicians are listed under General Practice with a practice address in Los Angeles, CA (1,964 in California).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Los Angeles

9.5% of these 169 clinicians have the CMS telehealth indicator.

24.3% of these 169 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 24 records totaling $538.55.

Manufacturer Payment Nature Product Type Amount ($)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $33.24
Gilead Sciences, Inc.
Food and Beverage
In-kind items and services
— General $32.39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $32.32
Teva Pharmaceuticals USA, Inc.
Food and Beverage
In-kind items and services
AUSTEDO XR General $30.70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $30.69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $30.30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $30.29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $28.95
Eli Lilly and Company
Food and Beverage
In-kind items and services
MOUNJARO General $28.93
Eli Lilly and Company
Food and Beverage
In-kind items and services
MOUNJARO General $28.08
Gilead Sciences, Inc.
Food and Beverage
In-kind items and services
— General $27.36
Teva Pharmaceuticals USA, Inc.
Food and Beverage
In-kind items and services
AUSTEDO XR General $26.70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $25.40
Teva Pharmaceuticals USA, Inc.
Food and Beverage
In-kind items and services
AUSTEDO XR General $25.02
Xeris Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
GVOKE HYPOPEN General $21.72
Xeris Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
GVOKE HYPOPEN General $21.13
Xeris Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
GVOKE HYPOPEN General $17.20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $12.50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $11.86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $10.91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $10.33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $10.15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $9.94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Food and Beverage
In-kind items and services
CAPLYTA General $2.44

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
1,605 456 $110.00 $91.52
96132 Evaluation of neuropsychological test, first hour
998 321 $200.00 $126.33
96138 Administration of psychological or neuropsychological test by technician, first 30 minutes
995 321 $100.00 $37.15
36415 Insertion of needle into vein for collection of blood sample
632 483 $11.89 $7.95
94375 Test to measure rate of airflow
593 452 $60.00 $40.71
94618 Test for exercise-induced lung stress
593 452 $100.00 $34.30
94200 Test to measure largest amount of air breathed in an out
592 451 $50.00 $15.79
94727 Test to determine lung volumes using gas dilution or washout
592 452 $70.00 $47.01
94729 Test to examine how well the lungs exchange gases
572 445 $100.00 $60.37
76872 Ultrasound scan of pelvic region through rectum
401 306 $180.00 $147.16
71046 X-ray of chest, 2 views
389 319 $80.00 $35.35
93975 Complete ultrasound of abdomen and pelvis artery and vein blood flow
225 189 $320.00 $279.65
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
198 198 $130.00 $112.95
76700 Complete ultrasound scan of abdomen
188 166 $200.00 $121.68
99442 Telephone medical discussion with physician, 11-20 minutes
125 59 $220.00 $92.41
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
108 20 $100.00 $39.21
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
96 25 $120.00 $49.76
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
66 64 $30.00 $14.52
99483 Assessment of and care planning for patient with impaired thought processing, typically 60 minutes
58 56 $420.00 $275.07
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
49 15 $150.00 $51.13
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
48 39 $120.00 $55.52
93040 Electrocardiogram (ecg) 1 to 3 leads with review by physician
42 41 $20.00 $13.19
76775 Limited ultrasound scan behind abdominal cavity
40 33 $200.00 $61.57
72100 X-ray of lower and sacral spine, 2-3 views
20 20 $180.00 $42.22
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a
18 12 $80.00 $46.48

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Amlodipine Besylate Amlodipine Besylate 550 30,666 $2,328.16 188
Atorvastatin Calcium Atorvastatin Calcium 539 27,505 $3,619.96 181
Gabapentin Gabapentin 353 13,133 $4,154.23 122
Albuterol Sulfate Hfa Albuterol Sulfate 346 14,237 $12,678.64 158
Metformin Hcl Metformin Hcl 338 16,440 $2,240.33 124
Omeprazole Omeprazole 271 13,195 $2,305.45 98
Losartan Potassium Losartan Potassium 266 13,680 $2,017.75 89
Ibuprofen Ibuprofen 263 6,981 $1,682.46 95
Tamsulosin Hcl Tamsulosin Hcl 260 11,761 $2,484.92 103
Lisinopril Lisinopril 233 13,211 $953.77 83
Furosemide Furosemide 221 9,280 $799.60 75
Hydrochlorothiazide Hydrochlorothiazide 207 13,419 $340.67 77
Quetiapine Fumarate Quetiapine Fumarate 158 6,699 $2,537.10 44
Carvedilol Carvedilol 149 5,488 $1,385.85 39
Trazodone Hcl Trazodone Hcl 142 5,435 $1,420.43 40
Levothyroxine Sodium Levothyroxine Sodium 135 6,310 $1,553.26 46
Glipizide Glipizide 125 7,608 $584.03 45
Alprazolam Alprazolam 119 3,510 $858.10 23
Sertraline Hcl Sertraline Hcl 105 3,780 $785.45 33
Pantoprazole Sodium Pantoprazole Sodium 97 4,710 $1,109.50 35
Metoprolol Succinate Metoprolol Succinate 91 4,200 $1,025.06 32
Diclofenac Sodium Diclofenac Sodium 90 2,163 $1,144.71 33
Mirtazapine Mirtazapine 89 3,030 $984.85 21
Cyclobenzaprine Hcl Cyclobenzaprine Hcl 80 2,725 $985.09 35
Metoprolol Tartrate Metoprolol Tartrate 78 4,127 $316.06 27

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2026-09-25
General Practice Primary Specialty

NUCC Taxonomy Code: 208D00000X

License # reported to NPPES CA A76121

A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.

Radiology - Diagnostic Radiology

NUCC Taxonomy Code: 2085R0202X

License # reported to NPPES CA A76121

A radiologist who utilizes x-ray, radionuclides, ultrasound and electromagnetic radiation to diagnose and treat disease.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Medical Board of California.
Look Up on State Board Site

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

1 listed
NPI 1588062566

Doctor of Medicine (M.D.)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

9 Historical Events
📍
Updated Practice Location September 25, 2026

Registered at 4300 CRENSHAW BLVD, LOS ANGELES, CA 900084902 (Tel: 3232981668)

📍
Updated Business Mailing Address September 25, 2026

Registered at 1689 E JEFFERSON AVE, POMONA, CA 917674548 (Tel: 6616449348)

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) September 25, 2026

General Practice (license number reported to NPPES: CA A76121)

✅
NPI Profile Active December 10, 2014

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) December 10, 2014

Registered at 10701 RIVERSIDE DR, SUITE 16, TOLUCA LAKE, CA 916022384 (Tel: 8189851221)

📍
Business Mailing Address (Initial Record) December 10, 2014

Registered at 10701 RIVERSIDE DR, 16, TOLUCA LAKE, CA 916022384 (Tel: 8189851221)

👤
Provider Name / Credentials (Initial Record) December 10, 2014

Recorded as BRIAN GAMBLE, M.D.

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) December 10, 2014

Nuclear Medicine (license number reported to NPPES: CA A76121)

🟢
Initial NPI Registration & Enumeration July 31, 2006

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1568478436
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: July 31, 2006
Last Update: September 25, 2026
Sole Proprietor: Yes

Other General Practices in Los Angeles

All General Practices in Los Angeles

Mailing Address

1689 E Jefferson Ave

Pomona, CA 917674548

Phone: 6616449348

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.